Your browser doesn't support javascript.
loading
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.
Quattrone, Diego; Reininghaus, Ulrich; Richards, Alex L; Tripoli, Giada; Ferraro, Laura; Quattrone, Andrea; Marino, Paolo; Rodriguez, Victoria; Spinazzola, Edoardo; Gayer-Anderson, Charlotte; Jongsma, Hannah E; Jones, Peter B; La Cascia, Caterina; La Barbera, Daniele; Tarricone, Ilaria; Bonora, Elena; Tosato, Sarah; Lasalvia, Antonio; Szöke, Andrei; Arango, Celso; Bernardo, Miquel; Bobes, Julio; Del Ben, Cristina Marta; Menezes, Paulo Rossi; Llorca, Pierre-Michel; Santos, Jose Luis; Sanjuán, Julio; Arrojo, Manuel; Tortelli, Andrea; Velthorst, Eva; Berendsen, Steven; de Haan, Lieuwe; Rutten, Bart P F; Lynskey, Michael T; Freeman, Tom P; Kirkbride, James B; Sham, Pak C; O'Donovan, Michael C; Cardno, Alastair G; Vassos, Evangelos; van Os, Jim; Morgan, Craig; Murray, Robin M; Lewis, Cathryn M; Di Forti, Marta.
Afiliação
  • Quattrone D; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, SE5 8AF, London, UK. diego.quattrone@kcl.ac.uk.
  • Reininghaus U; National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, UK. diego.quattrone@kcl.ac.uk.
  • Richards AL; Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, 68159, Germany. diego.quattrone@kcl.ac.uk.
  • Tripoli G; Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, 68159, Germany.
  • Ferraro L; Department of Health Service and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
  • Quattrone A; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
  • Marino P; Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, CF24 4HQ, UK.
  • Rodriguez V; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Via G. La Loggia 1, 90129, Palermo, Italy.
  • Spinazzola E; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Via G. La Loggia 1, 90129, Palermo, Italy.
  • Gayer-Anderson C; National Health Care System, Villa Betania Psychological Institute, 89100, Reggio Calabria, Italy.
  • Jongsma HE; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
  • Jones PB; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
  • La Cascia C; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
  • La Barbera D; Department of Health Service and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
  • Tarricone I; Psylife Group, Division of Psychiatry, University College London, 6th Floor, Maple House, 149 Tottenham Court Road, London, W1T 7NF, UK.
  • Bonora E; Centre for Transcultural Psychiatry "Veldzicht" Balkbrug, the Netherlands, VR Mental Health Group, University Center for Psychiatry, Univerisity Medical Centre Groningen, Groningen, The Netherlands.
  • Tosato S; Department of Psychiatry, University of Cambridge, Herchel Smith Building for Brain & Mind Sciences, Forvie Site, Robinson Way, Cambridge, CB2 0SZ, UK.
  • Lasalvia A; CAMEO Early Intervention Service, Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge, CB21 5EF, UK.
  • Szöke A; National Health Care System, Villa Betania Psychological Institute, 89100, Reggio Calabria, Italy.
  • Arango C; National Health Care System, Villa Betania Psychological Institute, 89100, Reggio Calabria, Italy.
  • Bernardo M; Department of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Viale Pepoli 5, 40126, Bologna, Italy.
  • Bobes J; Department of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Viale Pepoli 5, 40126, Bologna, Italy.
  • Del Ben CM; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.
  • Menezes PR; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.
  • Llorca PM; INSERM, U955, Equipe 15, 51 Avenue de Maréchal de Lattre de Tassigny, 94010, Créteil, France.
  • Santos JL; Child and Adolescent Psychiatry Department, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, C/Doctor Esquerdo 46, 28007, Madrid, Spain.
  • Sanjuán J; Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Department of Medicine, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
  • Arrojo M; Faculty of Medicine and Health Sciences - Psychiatry, Universidad de Oviedo, ISPA, INEUROPA. CIBERSAM, Oviedo, Spain.
  • Tortelli A; Neuroscience and Behavior Department, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Velthorst E; Department of Preventative Medicine, Faculdade de Medicina FMUSP, University of São Paulo, São Paulo, Brazil.
  • Berendsen S; University Clermont Auvergne, CMP-B CHU, CNRS, Clermont Auvergne INP, Institut Pascal, F-63000, Clermont-Ferrand, France.
  • de Haan L; Department of Psychiatry, Servicio de Psiquiatría Hospital "Virgen de la Luz,", Cuenca, Spain.
  • Rutten BPF; Department of Psychiatry, School of Medicine, Universidad de Valencia, Centro de Investigación Biomédica en Red de Salud Mental, Valencia, Spain.
  • Lynskey MT; Department of Psychiatry, Psychiatric Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago, Spain.
  • Freeman TP; Etablissement Public de Santé Maison Blanche, Paris, France.
  • Kirkbride JB; Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
  • Sham PC; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • O'Donovan MC; Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
  • Cardno AG; Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
  • Vassos E; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
  • van Os J; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 4 Windsor Walk, London, SE5 8BB, UK.
  • Morgan C; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 4 Windsor Walk, London, SE5 8BB, UK.
  • Murray RM; Department of Psychology, University of Bath, 10 West, Bath, BA2 7AY, UK.
  • Lewis CM; Psylife Group, Division of Psychiatry, University College London, 6th Floor, Maple House, 149 Tottenham Court Road, London, W1T 7NF, UK.
  • Di Forti M; Department of Psychiatry, the University of Hong Kong, Pok Fu Lam, Hong Kong.
Transl Psychiatry ; 11(1): 423, 2021 08 10.
Article em En | MEDLINE | ID: mdl-34376640
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Problema de saúde: 2_sustancias_psicoativas / 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders Assunto principal: Transtornos Psicóticos / Esquizofrenia / Cannabis Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Transl Psychiatry Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Problema de saúde: 2_sustancias_psicoativas / 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders Assunto principal: Transtornos Psicóticos / Esquizofrenia / Cannabis Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Transl Psychiatry Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido